News / Multiple Sclerosis

    Combinostics Partnership with ConcertAI's TeraRecon adds AI-based Evaluations for Neurodegenerative Disease and Multiple Sclerosis to Eureka Clinical AI

    by TeraRecon, on Apr 27, 2023 3:49:24 PM

    Combinostics Partnership with ConcertAI's TeraRecon adds AI-based Evaluations for Neurodegenerative Disease and Multiple Sclerosis to Eureka Clinical AI

    CAMBRIDGE, Mass., April 27, 2023 /PRNewswire/ -- The Eureka Clinical AI platform, from ConcertAI's TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to bring …

    Read Story
    Prev All Posts Next

    About TeraRecon

    TeraRecon is a leader in advanced visualization, artificial intelligence, image viewing, and post-processing.

    Learn More →

    Subscribe to Receive News Updates

    TeraRecon, Inc

    TeraRecon Headquarters
    4309 Emperor Blvd, Suite 310
    Durham, NC 27703 
    Tel: 650.372.1100
    Fax: 650.372.1101
    info@terarecon.com 

     

    All offerings are subject to availability and regulatory clearance, which may vary by country. Please verify product status with your local TeraRecon representative.

     

    Additional Resources

    Subscribe to our newsletter

    ©2024 Terarecon, Inc. All Rights Reserved.